Qifeng Chen1 article listing Qifeng Chen in Nature Communications, indexed by Paperzzz from Crossref and OSF.Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study Nature Communications